News

Webcast Image Webcast
Q2 2020 IRIDEX Earnings Conference Call
08/06/20 at 5:00 PM EDT

Date Title Teaser
11/07/19
Summary ToggleIRIDEX Announces 2019 Third Quarter Financial Results MOUNTAIN VIEW, Calif. , Nov. 07, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the third quarter ended September 28, 2019 . Third Quarter Highlights Total revenue of $10.7 million Cyclo G6® product family revenue of $3.0 million , a 3.6%
11/05/19
Summary ToggleIRIDEX to Present at the 2019 Stifel Healthcare Conference MOUNTAIN VIEW, Calif. , Nov. 05, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the upcoming Stifel Healthcare Conference in New York City . David I. Bruce , IRIDEX’s President and Chief Executive Officer, is scheduled to present on
10/28/19
Summary ToggleIRIDEX Announces Appointment of Robert Gunst as Chairman of the Board of Directors and Departure of Lead Independent Director, Ruediger Naumann-Etienne MOUNTAIN VIEW, Calif. , Oct. 28, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the appointment of Robert Gunst as Chairman of the Board, effective October 23, 2019 . Concurrent with this appointment, Ruediger Naumann-Etienne departed from the Board of Directors as Lead
10/24/19
Summary ToggleIRIDEX to Report Third Quarter 2019 Financial Results on November 7, 2019 MOUNTAIN VIEW, Calif. , Oct. 24, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the third quarter of 2019 after the close of trading on Thursday, November 7 , 2019.  The Company’s management team will host a corresponding
09/11/19
Summary ToggleMicroPulse® Transscleral Laser Therapy Will be Discussed in Various Presentations and Educational Events at ESCRS 2019 in Paris, France MOUNTAIN VIEW, Calif. , Sept. 11, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today that its patented MicroPulse® laser therapy will be featured prominently
08/06/19
Summary ToggleIRIDEX Announces 2019 Second Quarter Financial Results MOUNTAIN VIEW, Calif. , Aug. 06, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the second quarter ended June 29, 2019 . Second Quarter Highlights Total revenue of $10.4 million ○  Cyclo G6 product family revenue of $3.4 million , an 11% increase
07/23/19
Summary ToggleIRIDEX to Report Second Quarter 2019 Financial Results on August 6, 2019 MOUNTAIN VIEW, Calif. , July 23, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the second quarter of 2019 after the close of trading on Tuesday, August 6 , 2019.  The Company’s management team will host a corresponding
05/21/19
Summary ToggleIRIDEX Announces Leadership Transition; David Bruce Appointed President and CEO MOUNTAIN VIEW, Calif. , May 21, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation  (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced the appointment of David Bruce to be the company’s President and Chief
05/02/19
Summary ToggleIRIDEX Announces 2019 First Quarter Financial Results MOUNTAIN VIEW, Calif. , May 02, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the first quarter ended March 30, 2019 . First Quarter Highlights Total revenue of $10.6 million , an 11% increase year-over-year Cyclo G6® product revenue of $3.1 million
04/29/19
Summary ToggleIRIDEX’s MicroPulse® Laser Technology Featured in Several Glaucoma and Retina Research Presentations at Major Ophthalmic Industry Conferences MOUNTAIN VIEW, Calif. , April 29, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today that its patented MicroPulse® technology played a pivotal role in
04/29/19
Summary ToggleScott Shuda Appointed to IRIDEX Board of Directors MOUNTAIN VIEW, Calif. , April 29, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today that Scott Shuda has been appointed to its board of directors, effective
04/18/19
Summary ToggleIRIDEX to Report First Quarter 2019 Financial Results on May 2, 2019 MOUNTAIN VIEW, Calif. , April 18, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the first quarter of 2019 after the close of trading on Thursday, May 2 , 2019.  The Company’s management team will host a corresponding
04/02/19
Summary ToggleKen Ludlum Appointed to IRIDEX Board of Directors MOUNTAIN VIEW, Calif. , April 02, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today that Ken Ludlum has been appointed to its Board of Directors, effective
04/01/19
Summary ToggleMicroPulse TSCPC featured in multiple abstracts, posters, presentations and wet lab at the World Glaucoma Congress
03/18/19
Summary ToggleIRIDEX to Present at the Spring Investor Summit MOUNTAIN VIEW, Calif. , March 18, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to present at the upcoming Spring Investor Summit in New York, NY . Chairman and CEO William Moore is scheduled to present on Monday, April 1, 2019 at 3:00 PM ET . 
03/06/19
Summary ToggleIRIDEX to Present at the 31st Annual Roth Conference MOUNTAIN VIEW, Calif. , March 06, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to present at the upcoming 31 st Annual Roth Conference in Orange County, CA. Management is scheduled to present on Tuesday, March 19, 2019 at 9:00 AM PT .  Interested
03/05/19
Summary ToggleIRIDEX Announces 2018 Fourth Quarter and Full Year Financial Results MOUNTAIN VIEW, Calif. , March 05, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the fourth quarter and year ended December 29, 2018 . Fourth Quarter Highlights Cyclo G6 ® product revenue increased approximately 16% year-over-year Shipped a record
02/26/19
Summary ToggleIRIDEX to Report Fourth Quarter and 2018 Financial Results on March 5, 2019 MOUNTAIN VIEW, Calif. , Feb. 26, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the fourth quarter and full year 2018 after the close of trading on Tuesday, March 5 , 2019.  The Company’s management team will host a
02/12/19
Summary ToggleIRIDEX Announces Resolution of its Dispute with Quantel Medical MOUNTAIN VIEW, Calif. , Feb. 12, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it has resolved its differences with Quantel Medical, S.A. , Quantel USA, Inc. , and Quantel, S.A. (collectively, “Quantel”) in its lawsuit filed against Quantel in the U.S.
01/08/19
Summary ToggleIRIDEX Announces Preliminary Operational and Financial Results for 2018 Fourth Quarter and Full Year MOUNTAIN VIEW, Calif. , Jan. 08, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today provided preliminary operational and financial results for the fourth quarter and full year ended December 29, 2018 . Highlights Shipped approximately 460 to 465 Cyclo G6® Glaucoma Laser Systems and
logo aa0 logo ags logo ascrs logo asrs logo esrs0 logo euretina